PT889735E - Métodos imunológicos para o tratamento do cancro gastrointestinal - Google Patents

Métodos imunológicos para o tratamento do cancro gastrointestinal Download PDF

Info

Publication number
PT889735E
PT889735E PT97905858T PT97905858T PT889735E PT 889735 E PT889735 E PT 889735E PT 97905858 T PT97905858 T PT 97905858T PT 97905858 T PT97905858 T PT 97905858T PT 889735 E PT889735 E PT 889735E
Authority
PT
Portugal
Prior art keywords
treatment
gastrointestinal cancer
immunological methods
gastrin
amidated
Prior art date
Application number
PT97905858T
Other languages
English (en)
Inventor
Philip C Gevas
Dov Michaeli
Stephen Grimes
Stephen L Karr
Susan A Watson
Original Assignee
Cancer Advances Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Advances Inc filed Critical Cancer Advances Inc
Publication of PT889735E publication Critical patent/PT889735E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/595—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT97905858T 1996-02-08 1997-02-07 Métodos imunológicos para o tratamento do cancro gastrointestinal PT889735E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1141196P 1996-02-08 1996-02-08
PCT/US1997/002029 WO1997028821A1 (en) 1996-02-08 1997-02-07 Immunological methods for the treatment of gastrointestinal cancer

Publications (1)

Publication Number Publication Date
PT889735E true PT889735E (pt) 2011-07-19

Family

ID=21750270

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97905858T PT889735E (pt) 1996-02-08 1997-02-07 Métodos imunológicos para o tratamento do cancro gastrointestinal

Country Status (9)

Country Link
US (1) US20050025770A1 (pt)
EP (1) EP0889735B1 (pt)
JP (3) JP2000504692A (pt)
AT (1) ATE505202T1 (pt)
DE (1) DE69740173D1 (pt)
DK (1) DK0889735T3 (pt)
ES (1) ES2361474T3 (pt)
PT (1) PT889735E (pt)
WO (1) WO1997028821A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69740173D1 (de) * 1996-02-08 2011-05-26 Cancer Advances Inc Immunologische methoden zur behandlung von gastrointestinalem krebs
US20040001842A1 (en) * 1997-05-12 2004-01-01 Dov Michaeli Immunogenic compositions to the CCK-B/gastrin receptor and methods for the treatment of tumors
EP0981369B1 (en) * 1997-05-12 2004-11-17 Aphton Corporation Immunogenic compositions to the cck-b/gastrin-receptor and methods for the treatment of tumors
EP1897556A1 (en) * 1998-05-15 2008-03-12 Receptor Biologix, Inc. Prevention and treatment of hypergastrinemia
WO1999059631A1 (en) * 1998-05-15 1999-11-25 Aphton Corporation Prevention and treatment of hypergastrinemia
US20030068326A1 (en) * 1998-05-15 2003-04-10 Aphton Corporation Method for the treatment of gastroesophageal reflux disease
US20030091574A1 (en) * 2001-03-23 2003-05-15 Gevas Philip C. Combination treatment of pancreatic cancer
US20090191232A1 (en) * 2001-05-04 2009-07-30 Gevas Philip C Combination therapy for the treatment of tumors
CA2450898A1 (en) * 2001-07-09 2003-01-23 Aphton Corporation Treatment and prevention of cancerous and pre-cancerous conditions of the liver, lung and esophagus
US20050169979A1 (en) * 2002-07-03 2005-08-04 Dov Michaeli Liposomal vaccine
US7235376B2 (en) 2003-03-28 2007-06-26 Receptor Biologix, Inc. Gastrin hormone immunoassays
WO2005095459A2 (en) * 2004-03-29 2005-10-13 Receptor Biologix, Inc. Monoclonal antibodies to gastrin hormone
DK1794586T3 (da) * 2004-09-22 2013-05-13 Cancer Advances Inc Monoklonale antistoffer til progastrin
JP5558660B2 (ja) 2007-05-11 2014-07-23 日東電工株式会社 両面接着性感圧接着シート
US8674064B2 (en) * 2010-03-03 2014-03-18 Onkologix Ltd Immunogenic compositions against human progastrin peptides
CN101797382B (zh) 2010-03-03 2013-11-20 戚胜美 抗人前胃液素多肽免疫组合物
HUE037252T2 (hu) 2013-05-21 2018-08-28 Tyg Oncology Ltd Gasztrin peptid immunogenikus kompozíció
JP6525909B2 (ja) 2016-03-15 2019-06-05 中外炉工業株式会社 工業炉
CA3066756A1 (en) 2017-06-15 2018-12-20 Cancer Advances Inc. Compositions and methods for inducing humoral and cellular immunities against tumors and cancer

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20119A (en) * 1858-04-27 Improvement in raking and delivering attachments to harvesters
US69966A (en) * 1867-10-22 Joseph chadwick
US1842A (en) * 1840-10-31 Machine fob cutting corks
US86941A (en) * 1869-02-16 Improvement in corn-planter
US95028A (en) * 1869-09-21 Improved process for preserving eggs
US58040A (en) * 1866-09-18 Improvement in making bolts
US187152A (en) * 1877-02-06 Improvement in clothes-wringers
US91574A (en) * 1869-06-22 Improvement in water-closet valves
US21786A (en) * 1858-10-12 Improvement in the manufacture of sugar
US39911A (en) * 1863-09-15 Improvement in corset skirt-supporters
US140962A (en) * 1873-07-15 Improvement in feeding paper to printing-presses
US68326A (en) * 1867-08-27 Alcibiades j
US4691006A (en) * 1983-03-04 1987-09-01 Ohio State University Antigenic modification of polypeptides
US4526716A (en) * 1981-11-20 1985-07-02 The Ohio State University Antigenic modification of polypeptides
US4384995A (en) * 1980-01-16 1983-05-24 The Ohio State University Antigenic modification of polypeptides
IT1179894B (it) * 1984-12-27 1987-09-16 Rotta Research Lab Proglumide e composizioni farmaceutiche che la contengono per l impiego nella terapia di affezioni neoplastiche
US6861510B1 (en) * 1989-01-24 2005-03-01 Aphton Corporation Immunogenic compositions against gastrin peptides
ATE114160T1 (de) * 1989-01-24 1994-12-15 Aphton Corp Immunogenische zusammensetzungen gegen gastrin- peptide.
US5023077A (en) 1989-01-24 1991-06-11 Aphton Corporation Immunogenic compositions and methods for the treatment and prevention of gastric and duodenal ulcer disease
US5319073A (en) * 1992-02-07 1994-06-07 The United States Of America, As Represented By The Department Of Health & Human Services Method of purifying cholecystokinin receptor protein
US5759551A (en) * 1993-04-27 1998-06-02 United Biomedical, Inc. Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
US5468494A (en) * 1993-11-12 1995-11-21 Aphton Corp. Immunogenic compositions against human gastrin 17
US5688506A (en) * 1994-01-27 1997-11-18 Aphton Corp. Immunogens against gonadotropin releasing hormone
FI97304C (fi) * 1994-11-16 1996-11-25 Locus Genex Oy Menetelmä mahasyövän riskin seulonnaksi
US6359114B1 (en) * 1995-06-07 2002-03-19 Aphton Corp. System for method for the modification and purification of proteins
DE69740173D1 (de) * 1996-02-08 2011-05-26 Cancer Advances Inc Immunologische methoden zur behandlung von gastrointestinalem krebs
EP0981369B1 (en) * 1997-05-12 2004-11-17 Aphton Corporation Immunogenic compositions to the cck-b/gastrin-receptor and methods for the treatment of tumors
WO2000050059A1 (en) * 1999-02-24 2000-08-31 The Uab Research Foundation Taxane derivatives for targeted therapy of cancer

Also Published As

Publication number Publication date
EP0889735A1 (en) 1999-01-13
JP5200269B2 (ja) 2013-06-05
JP2000504692A (ja) 2000-04-18
US20050025770A1 (en) 2005-02-03
JP2007126461A (ja) 2007-05-24
EP0889735B1 (en) 2011-04-13
JP2012097062A (ja) 2012-05-24
DK0889735T3 (da) 2011-08-08
ATE505202T1 (de) 2011-04-15
JP5200251B2 (ja) 2013-06-05
DE69740173D1 (de) 2011-05-26
ES2361474T3 (es) 2011-06-17
WO1997028821A1 (en) 1997-08-14

Similar Documents

Publication Publication Date Title
PT889735E (pt) Métodos imunológicos para o tratamento do cancro gastrointestinal
WO1997028821B1 (en) Immunological methods for the treatment of gastrointestinal cancer
IL139700A0 (en) Immunotherapeutic composition and method for the treatment of prostate cancer
NZ332566A (en) Antigen binding fragments that specifically detect cancer cells
AR243080A1 (es) Procedimiento para obtener un complejo inmunogenico entre proteinas antigenicas o peptidos con regiones hidrofobas y bisdesmosidos con regiones hidrofobas.
PL332742A1 (en) Transformed human antibody against hm 1.24
MX9701859A (es) Anticuerpos monoclonales en contra de antigenos asociados con carcinoma de colon humano, y usos de los mismos.
IL125590A0 (en) Peptide immunogens
EP0380230A3 (en) Immunogenic compositions against gastrin peptides
NZ331978A (en) Monoclonal antibody to CEA (carcinomembryonic antigen), conjugates comprising said antibody, and their therapeutic use in an adept system
EP0643559A4 (en) DIPHTHERIA TOXIN RECEPTOR BINDING REGION.
MD1374G2 (ro) Anticorpi monoclonali imunostimulatori, procedeu de obţinere a acestora, linii celulare, metodă de tratare a maladiilor şi compoziţie farmaceutică
IL126803A0 (en) Method and composition for reconforming multi-epitopic antigens to initiate an immune response
NZ205241A (en) Synthetic human (pre)prorelaxin; synthetic signal, a, b and c peptide chains thereof; preparation of human preprorelaxin, prorelaxin and relaxin by recombinant dna or other techniques
PL325897A1 (en) Patient-specific immunoadsorbents for extracorporeal apherresis and method of obtaining them
ZA972757B (en) Porphyromonas gingivalis antigents for the diagnosis and treatment of periodontitis.
WO2000069915A3 (en) COMBINED APPROACH TO TREATMENT OF CANCER WITH hCG VACCINES
EP0109434A4 (en) IN VITRO DIAGNOSTICS METHODS USING MONOCLONAL ANTIBODIES AGAINST PROTEINS OF CONNECTIVE TISSUES.
EP0420848A4 (en) Carcinoma-associated antigens, and antibodies which recognize these antigens
WO1991010735A3 (fr) Recepteur humain de la tsh. sequence codant pour ce recepteur
EP0821060A3 (de) E-Cadherin-Mutationen als Grundlage zur Diagnostik und Therapie humaner maligner Tumoren
ATE234109T1 (de) Cetp zur erhöhung des hdl-cholesterol-gehalts
HU9300928D0 (en) Endothelial-leucocyta adhesion molecule-1 (elam-1) and its antibodies being applicable for treatment of asthma
ATE286914T1 (de) Verwendung von blockierenden anti-tsh-rezeptor- antikörpern bei der therapie von hyperthyreosen sowie monoklonale antikörper für eine solche verwendung
DE69615537D1 (en) Helicobacter pylori antigen